CG
XBIT icon

Cutler Group’s XBiotech XBIT Stock Holding History

Cutler Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,264
Closed -$31.8K – 4983
2020
Q1 		$24K Buy
+2,264
New +$36.9K ﹤0.01% 2185
2018
Q2 		– Sell
-1,535
Closed -$8K – 5003
2018
Q1 		$8K Buy
1,535
+1,235
+412% +$5.69K ﹤0.01% 2986
2017
Q4 		$1K Sell
300
-6,234
-95% -$26.2K ﹤0.01% 4623
2017
Q3 		$28K Sell
6,534
-5,563
-46% -$26.3K ﹤0.01% 2810
2017
Q2 		$56K Buy
12,097
+8,497
+236% +$81.4K ﹤0.01% 2385
2017
Q1 		$59K Sell
3,600
-2,218
-38% -$29K ﹤0.01% 2238
2016
Q4 		$58K Sell
5,818
-5,976
-51% -$79.5K ﹤0.01% 2398
2016
Q3 		$158K Buy
+11,794
New +$173K 0.01% 1422

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cutler Group's XBIT Position: Q2 2020 in Review

Cutler Group sold out of XBiotech (XBIT) in Q2 2020, closing a stake of 2,264 shares — an estimated $31.8K sold.

Cutler Group first reported a position in XBIT in Q3 2016 and held it in 8 quarters. The position peaked at $158K in Q3 2016. 65 funds tracked by Wall St. Rank hold XBIT as of Q2 2020.

  • Cutler Group reported no remaining XBiotech position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 2,264 XBiotech shares in Q2 2020, an estimated $31.8K.
  • Cutler Group first reported a position in XBiotech in Q3 2016 and held it in 8 quarters.
  • Cutler Group's XBiotech position peaked at $158K in Q3 2016.
  • 65 funds tracked by Wall St. Rank held XBiotech as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.